Latest content from Pharmetheus.
Our team worked on M&S for imeglimin in T2DM patients to support dose recommendations in patients with renal impairment, see the poster presented at PAGE by Enrica Mezzalana here
Enrica Mezzalana, Ph.D.
Pharmetheus ABDag Hammarskjölds väg 36B752 37 Uppsala, Swedeninfo@pharmetheus.com+46(0)18-51 33 28
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..